Clinical Trials on Genetic Diseases, Inborn in Canada
Total 25144 results
-
GlaxoSmithKlineRecruitingDermatitis, AtopicSpain, Bulgaria, Germany, Korea, Republic of, Canada, Argentina, China, United States, Poland, Italy, Czechia, Japan, Panama, Greece, Thailand, France, Mexico
-
Regeneron PharmaceuticalsSanofiCompletedHypercholesterolemia | Heterozygous Familial HypercholesterolemiaUnited States, Canada
-
University of British ColumbiaRecruiting
-
Ionis Pharmaceuticals, Inc.Active, not recruitingFamilial Chylomicronemia SyndromeUnited States, Canada, Sweden
-
Ultragenyx Pharmaceutical IncActive, not recruitingGlycogen Storage Disease Type IA | Von Gierke's Disease (GSD Type Ia)Netherlands, United States, Canada, Spain
-
AlexionCompletedWolman Disease | Lysosomal Acid Lipase DeficiencyUnited States, Canada, United Kingdom, Italy, France
-
AB2 Bio Ltd.Active, not recruitingNLRC4-MAS | XIAP DeficiencyUnited States, Canada, Germany
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCCompletedMucopolysaccharidosis I | Hurler-Scheie Syndrome | Hurlers SyndromeUnited States, Canada, Germany
-
University of British ColumbiaThe Hospital for Sick ChildrenRecruitingCystic FibrosisCanada
-
Nova Mentis Life Science CorpKGK Science Inc.SuspendedCognitive Dysfunction | Fragile X Syndrome | BehaviorCanada
-
SynlogicTerminatedPhenylketonuriaUnited States, Canada, Georgia, Turkey
-
Asana BioSciencesCompletedDermatitis, Atopic | Dermatitis, Eczematous | Dermatitis EczemaUnited States, Canada
-
The Hospital for Sick ChildrenCompleted
-
CancerCare ManitobaThe Hospital for Sick Children; Novo Nordisk A/SCompleted
-
Xencor, Inc.Active, not recruitingPsoriasis | Atopic DermatitisUnited States, Canada
-
McMaster UniversityNot yet recruiting
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States, Canada
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase Deficiency | LAL-Deficiency | Cholesterol Ester Storage Disease (CESD)France, United Kingdom, United States, Canada, Czechia
-
The Hospital for Sick ChildrenRecruiting
-
Wave Life Sciences Ltd.RecruitingAlpha-1 Antitrypsin DeficiencyCanada
-
Arrowhead PharmaceuticalsCompletedHypertriglyceridemia | Familial ChylomicronemiaAustralia, Canada, New Zealand
-
Asana BioSciencesCompletedDermatitis, Atopic | Pruritus | Dermatitis EczemaUnited States, Canada
-
Sangamo TherapeuticsActive, not recruitingFabry DiseaseUnited States, United Kingdom, Taiwan, Australia, Germany, Italy, Canada
-
Escient Pharmaceuticals, IncActive, not recruiting
-
Holland Bloorview Kids Rehabilitation HospitalChildren's Hospital of Eastern OntarioCompletedMuscular Dystrophies | Congenital MyopathyCanada
-
West Park Healthcare CentreCompletedCystic Fibrosis in ChildrenCanada
-
Dermavant Sciences, Inc.CompletedAtopic DermatitisUnited States, Canada
-
Alexion Pharmaceuticals, Inc.Enrolling by invitationHypophosphatasia (HPP)United States, Italy, Russian Federation, Spain, United Kingdom, Germany, Canada, France, Saudi Arabia, Poland, Australia
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI)CompletedThalassemiaUnited States, Canada
-
NightstaRx Ltd, a Biogen CompanyCompletedChoroideremiaFinland, United States, Canada, Denmark, Netherlands, Germany, United Kingdom, Brazil, France
-
OctapharmaCompleted
-
Horizon Therapeutics, LLCCompletedUrea Cycle DisorderUnited States, Canada
-
The Hospital for Sick ChildrenRecruitingAsthma | Cystic FibrosisCanada
-
NS Pharma, Inc.Cooperative International Neuromuscular Research Group; Nippon Shinyaku Co.... and other collaboratorsCompletedDuchenne Muscular DystrophyUnited States, Canada
-
Akcea TherapeuticsRecruitingHereditary Transthyretin Amyloidosis With PolyneuropthyUnited States, Canada
-
The Hospital for Sick ChildrenCompleted
-
OctapharmaTerminated
-
Dignity Sciences Ltd.Completed
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedMucopolysaccharidosis Type I | Mucopolysaccharidosis Type II | Mucopolysaccharidosis Type VI | Mucopolysaccharidosis Type IV | Mucopolysaccharidosis Type VIIUnited States, Canada
-
Agios Pharmaceuticals, Inc.Active, not recruitingThalassemiaUnited States, Canada, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaNetherlands, United States, Canada, Russian Federation, South Africa
-
Université de SherbrookeRare Disease FoundationCompletedMyotonic Dystrophy 1Canada
-
Cynthia GagnonFondation du Grand défi Pierre LavoieCompletedEffects of a Multiple Component Training Program on Muscles in Adults With Myotonic Dystrophy Type 1Myotonic Dystrophy 1Canada
-
PfizerTerminatedHyperlipoproteinemia Type IIICanada, United States
-
Forma Therapeutics, Inc.Novo Nordisk A/SRecruitingSickle Cell DiseaseLebanon, Canada, Kenya, United Kingdom
-
Lokman Hekim ÜniversitesiCompletedParents | Duchenne Muscular Dystrophy | Psychoeducation | Psychological WellnessTurkey
-
LEO PharmaCompletedAtopic DermatitisUnited States, Canada, Germany, Poland
-
Novo Nordisk A/SCompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United States, United Kingdom, New Zealand, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompletedUrea Cycle DisordersUnited States, Canada